Subtype-Specific Dimerization of α1-Adrenoceptors: Effects on Receptor Expression and Pharmacological Properties

Molecular Pharmacology

Volumn 64, Issue 6, 2003, Pages 1379-1390

  Uberti, Michelle A ^a   Hall, Randy A ^a   Minneman, Kenneth P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; HEMAGGLUTININ; MONOMER; NORADRENALIN; OLIGOMER; PRAZOSIN; RECEPTOR SUBTYPE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; DRUG BINDING SITE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR DENSITY;

ADRENERGIC ALPHA-ANTAGONISTS; CELL LINE; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0346366929     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.6.1379     Document Type: Article

References (51)

1. Bai M, Trivedi S, and Brown EM (1998) Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol. Chem 273:23605-23610.
2. Bouvier M (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2:274-286.
3. 1-adrenoceptor subtypes. Mol Pharmacol 61:1008-1016.
4. Cvejic S and Devi LA (1997) Dimerization of the δ-opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964.
5. Daly CJ, Milligan CM, Milligan G, Mackenzie JF and McGrath JC (1998) Cellular localization and pharmacological characterization of functioning α1 adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors. J Pharmacol Exp Ther 286:984-990.
6. Endoh M (1996) Cardiac alpha(1)-adrenoceptors that regulate contractile function: subtypes and subcellular signal transduction mechanisms. Neurochem Res 21:217-229.
7. Esbenshade TA, Han C, Murphy TJ, and Minneman KP (1993) Comparison of α1-adrenergic receptor subtypes and signal transduction in SK-N-MC and NB41A3 neuronal cell lines. Mol Pharmacol 44:76-86.
8. Esbenshade TA, Hirasawa A, Tsujimoto G, Tanaka T, Yano J, Minneman KP, and Murphy TJ (1995) Cloning of the human α1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol Pharmacol 47:977-985.
9. Ford AP, Arredondo NF, Blue DR Jr, Bonhaus DW, Jasper J, Kava MS, Lesnick J, Pfister JR, Shieh IA, Vimont RL, et al. (1996) RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-α,α -dimethyl-1H-indole-3-ethanamine hydrochloride), a selective α1A-adrenoceptor antagonist, displays low affinity for functional α1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol 49:209-215.
10. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, and Clarke DE (1997) Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121:1127-1135.
11. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, and O'Dowd BF (2000) Oligomerization of μ-and δ-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135.
12. Gether U, Lin S, and Kobilka BK (1995) Fluorescent labeling of purified β2 adrenergic receptor. Evidence for ligand-specific conformational changes. J Biol Chem 270:28268-28275.
13. Graham RM, Perez DM, Hwa J, and Piascik MT (1996) Alpha 1-adrenergic receptor subtypes. Molecular structure, function and signaling. Circ Res 78:737-749.
14. Han CD and Minneman KP (1991) Interaction of subtype-selective antagonists with α-adrenergic receptor binding sites in rat tissues. Mol Pharmacol 40:531-538.
15. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, and Bouvier M (1996) A peptide derived from a β2-adrenergie receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392.
16. Heldin CH (1995) Dimerization of cell surface receptors in signal transduction. Cell 80:213-223.
17. Hirasawa A, Shibata K, Horie K, Takei Y, Obika K, Tanaka T, Muramoto N, Takagaki K, Yano J, and Tsujimoto G (1995) Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants. FEBS Lett 363:256-260.
18. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, and Tsujimoto G (1997) Subtype-specific differences in subcellular localization of α1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface α1-adrenoceptors irrespective of the subtype. Mol Pharmacol 52:764-770.
19. Johnson RD and Minneman KP (1986) Characterization of alpha 1-adrenoceptors which increase cyclic AMP accumulation in rat cerebral cortex. Eur J Pharmacol 129:293-305.
20. Jordan BA, Cvejic S, and Devi LA (2000) Opioids and their complicated receptor complexes. Neuropsychopharmacology 23:S5-S18.
21. Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature (Lond) 399:697-700.
22. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, and Devi LA (2001) Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 98:343-348.
23. Karpa KD, Lin R, Kabbani N, and Levenson R (2000) The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol Pharmacol 58:677-683.
24. Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, Villeneuve LR, Zhu WZ, Xiao RP, Lakatta EG, Bouvier M, et al. (2002) β1/ β2-adrenergic receptor heterodimerization regulates β2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 277:35402-35410.
25. Lei B, Zhang Y, and Han C (2002) Changes in mRNA expression induced by sustained noradrenaline stimulation are different for alpha1-adrenoceptor subtypes in HEK293 cells. Clin Exp Pharmacol Physiol 29:1084-1090.
26. Maggio R, Vogel Z, and Wess J (1993) Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc Natl Acad Sci USA 90:3103-3107.
27. Margeta-Mitrovic M, Jan YN, and Jan LY (2001) Function of GB1 and GB2 subunits in G protein coupling of GABA(B) receptors. Proc Natl Acad Sci USA 98:14649-14654.
28. 1D-adrenoceptors by agonists and inverse agonists. Mol Pharmacol 57:659-666.
29. Michelotti GA, Price DT, and Schwinn DA (2000) Alpha 1-adrenergic receptor regulation: basic science and clinical implications. Pharmacol Ther 88:281-309.
30. Muramatsu I, Murata S, Isaka M, Piao HL, Zhu J, Suzuki F, Miyamoto S, Oshita M, Watanabe Y, and Taniguchi T (1998) Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues. Life Sci 62, 1461-1465.
31. Noguchi H, Muraoka R, Kigoshi S, and Muramatsu I (1993) Alpha 1-adrenoceptor subtype involved in the positive inotropic response to phenylephrine in rat atria. Eur J Pharmacol 240:291-293.
32. Noguchi H, Muraoka R, Kigoshi S, and Muramatsu I (1995) Pharmacological characterization of alpha 1-adrenoceptor subtypes in rat heart: a binding study. Br J Pharmacol 114:1026-1030.
33. Perez DM, DeYoung MB, and Graham RM (1993) Coupling of expressed β1B- and α1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specific. Mol Pharmacol 44:784-795.
34. Piascik MT, Hrometz SL, Edelmann SE, Guarino RD, Hadley RW, and Brown RD (1997) Immunocytochemical localization of the α-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J Pharmacol Exp Ther 283:854-868.
35. Price DT, Lefkowitz RJ, Caron MG, Berkowitz D, and Schwinn DA (1994) Localization of mRNA for three distinct α1-adrenergic receptor subtypes in human tissues: implications for human α-adrenergic physiology. Mol Pharmacol 45:171-175.
36. Pupo AS, Uberti MA, and Minneman KP (2003) N-terminal truncation of human alpha(1D)-adrenoceptors increases expression of binding sites but not protein. Eur J Pharmacol 462:1-8.
37. Ramarao CS, Denker JM, Perez DM, Gaivin RJ, Riek RP, and Graham RM (1992) Genomic organization and expression of the human α1B-adrenergic receptor. J Biol Chem 267:21936-21945.
38. Rios CD, Jordan BA, Gomes I, and Devi LA (2001) G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol Ther 92:71-87.
39. Robeva AS, Woodard R, Luthin DR, Taylor HE, and Linden J (1996) Double tagging recombinant A1- and A2A-adenosine receptors with hexahistidine and the FLAG epitope. Development of an efficient generic protein purification procedure. Biochem Pharmacol 51:545-555.
40. Rokosh DG, Stewart AF, Chang KC, Bailey BA, Karliner JS, Camacho SA, Long CS and Simpson PC (1996) α1-Adrenergic receptor subtype mRNAs are differentially regulated by α1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of α1B and α1D but induction of α1C. J Biol Chem 271:5839-5843.
41. Scarselli M, Armogida M, Chiacchio S, DeMontis MG, Colzi A, Corsini GU, and Maggio R (2000) Reconstitution of functional dopamine D(2s) receptor by coexpression of amino- and carboxyl-terminal receptor fragments. Eur J Pharmacol 397:291-296.
42. Schwinn DA (1994) Adrenergic receptors: unique localization in human tissues. Adv Pharmacol 31:333-341.
43. Schwinn DA, Johnston GI, Page SO, Mosley MJ, Wilson KH, Worman NP, Campbell S, Fidock MD, Furness LM, Parry-Smith DJ, et al. (1995) Cloning and pharmacological characterization of human α-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J Pharmacol Exp Ther 272:134-142.
44. Taguchi K, Yang M, Goepel M, and Michel MC (1998) Comparison of human alpha1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways. Naunyn Schmiedeberg's Arch Pharmacol 357:100-110.
45. Theroux TL, Esbenshade TA, Peavy RD, and Minneman KP (1996) Coupling efficiencies of human α1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 50:1376-1387.
46. Varma DR and Deng XF (2000) Cardiovascular alpha1-adrenoceptor subtypes: functions and signaling. Can J Physiol Pharmacol 78:267-292.
47. 1-adrenergic receptor subtypes. J Pharmacol Exp Ther 302:58-65.
48. Xie Z, Lee SP, O'Dowd BF, and George SR (1999) Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett 456:63-67.
49. Xu J, He J, Castleberry AM, Balasubramanian S, Lau AG, and Hall RA (2003) Heterodimerization of α2A- and β1-adrenergic receptors. J Biol Chem 278:10770-10777.
50. Zhong H and Minneman KP (1999) Alpha1-adrenoceptor subtypes. Eur J Pharmacol 375:261-276.
51. Zhu X and Wess J (1998) Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37:15773-15784.